QS Investors, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 213 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$95,000
+23.4%
1,5000.0%0.00%0.0%
Q1 2020$77,000
-34.7%
1,5000.0%0.00%0.0%
Q4 2019$118,000
+61.6%
1,5000.0%0.00%0.0%
Q3 2019$73,000
-7.6%
1,5000.0%0.00%0.0%
Q2 2019$79,000
-54.9%
1,500
-54.5%
0.00%
-50.0%
Q1 2019$175,000
+316.7%
3,300
+200.0%
0.00%
Q3 2018$42,000
-16.0%
1,1000.0%0.00%
Q2 2018$50,000
-5.7%
1,1000.0%0.00%
-100.0%
Q1 2018$53,0001,1000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders